The translational gap between academic science and the marketplace for innovation is well recognized. Small biotech ventures located outside US and Europe also face difficulty in accessing knowledge and capital needed to progress their innovation. We aim to be the bridge connecting disconnected pools of innovation to the global community of investors who may be interested in investing in these novel ideas. Our experts will provide detailed and impartial assessments of these innovations to help investors triage them rapidly for incorporation in their portfolios.